MET-PET/CT boosts myeloma lesion, adenoma diagnosis

12/3/2012 | (free registration)

A study presented at a radiology meeting found that the mean maximum standardized uptake value with carbon-11 methionine-PET/CT and FDG-PET/CT varied significantly between typical adenomas and normal glands and between atypical and typical adenomas. The findings indicate that both imaging methods can yield useful data to diagnose pituitary adenomas and help predict the likelihood of atypical adenoma prior to surgery. Another study presented at the same meeting found that MET-PET/CT had a higher sensitivity and accuracy than FDG-PET/CT in detecting multiple myeloma lesions, but the two methods had the same specificity. MET-PET/CT can be helpful in cases when FDG-PET/CT results come out as inconclusive or negative, researchers said.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN